What opportunities are available under Cooperation and the Health Theme?
Programme: Cooperation (collaborative research)
The 7th call for proposals under the Cooperation pillar has now closed.
Cooperation is the core programme of FP7 and has two thirds of the overall budget assigned to it (€32,413 million over seven years).
Cooperation provides funds for research projects (collaborative projects) and research coordination activities (coordination and support actions) across Europe and internationally. Consortia can consist of partners from the public and private sectors.
Cooperation consists of research to meet specific policy needs (i.e. ‘top down’ research). The funded projects must address the topics presented in the relevant work programme. The work programme can be obtained on the Participant Portal.
Research is carried out in ten key thematic areas:
1. Health
2. Food, Agriculture and Fisheries, Biotechnology
3. Information & communication technologies
4. Nanosciences, nanotechnologies, materials & new production technologies
5. Energy
6. Environment (including Climate Change)
7. Transport (including aeronautics)
8. Socio-economic Sciences and the Humanities
9. Space
10. Security
The ten thematic areas are illustrated in the chart below along with their budget allocation.
The Health Theme
The Health Theme has a total budget of €6.1 billion for FP7.
Latest call
The 7th and final call (HEALTH.2013) was published on the Participant Portal on the 10th July 2012 and has an indicative budget of ~€840 million.
The HEALTH.2013 work programme will cover many health research areas, however three have been identified as priorities:
- 1. Brain and brain related diseases: the indicative total budget is ~€126 million. Topics will include a 5 year longitudinal study on Traumatic Brain Injury (TBI), imaging tools for mental disorders, epilepsy and paediatric conduct disorders.
- 2. Antimicrobial resistance: the indicative total budget is ~€24 million. Calls will cover drug and vaccine development and stratified approaches to antibacterial and/or antifungal treatment.
- 3. Comparative Effectiveness Research (CER): this area is inclusive of the 5 year longitudinal study on Traumatic Brain Injury (TBI) but will also focus on existing technologies for cardiovascular prevention, diagnosis and treatment, as well as comparisons of health systems and services across Europe.
In the HEALTH.2013 work programme there will be two types of call:
HEALTH.2013.INNOVATION-1
- Proposal submission and evaluation: two-stage procedure
- Deadline for stage 1 proposals: 02 October 2012
HEALTH.2013.INNOVATION 2
- Proposal submission and evaluation: two-stage procedure
- Deadline for stage 1 proposals: 25 September 2012
Key points to note:
- only two calls - HEALTH.2013.0-1 and HEALTH.2013.2.3.1-1
- Consortium participants will be restricted to minimum of 3 EU Member State (MS) or Associated Country (AC) partners and a maximum of 5 MS or AC partners;
- Project duration may not exceed three years
- ≥50% SME involvement
If you have any questions in regards to call topics within the Health 2013 Theme then please contact the National Contact Point:
Victoria Brewer
Email: victoria.brewer@headoffice.mrc.ac.uk
Further information is available from the Patrticipant Portal website.
Health Theme Research
The Health Theme subject area for all calls under FP7 are divided into the following areas. Not all of these will be covered in every call.
1. Biotechnology, generic tools and medical technologies for human health
- High-throughput research to catalyse progress in developing new research tools for modern biology;
- Detection, diagnosis and monitoring (imaging, detection and analytical tools);
- Predicting suitability, safety and efficacy of therapies to mainly be implemented by the Innovative Medicines Initiative (IMI). For further information on IMI please access our IMI webpage; and
- Innovative therapeutic approaches and interventions (including immunotherapy & vaccines, stem cells, gene therapy).
2. Translating research for human health
- Integrating biological data and processes including large scale data gathering and systems biology;
- Research on the brain and related diseases;
- Translational research in major infectious diseases (anti-microbial drug resistance, HIV/AIDS, malaria & tuberculosis, emerging epidemics, neglected infectious diseases); and
- Translational research in other major diseases (cancer, cardiovascular disease, diabetes & obesity, rare diseases and other chronic diseases).
3. Optimising the delivery of healthcare to European citizens
- Translating clinical research outcomes into clinical practice;
- Quality, efficiency, solidarity and sustainability of health systems; and
- Enhanced health promotion and disease prevention.
Health: Strategic issues
In addition to the above research areas, certain issues are strategically important for all Health theme topics. These are child health and the health of the ageing population.
Other key strategic areas are:
- Research involving small to medium enterprises (SMEs); and
- Research with partners outside the EU.
For details about additional FP7 funding programmes please see other opportunities page.
Results from previous calls:
2010 Health Call Results
- 2010 Single Stage: 224 proposals were submitted and 68 have been taken forward to the grant agreement stage.
- 2010 Two Stage: 87 proposals were taken forward to the second stage and 36 have been taken forward to the grant agreement stage.
- 2010 Influenza Call: 13 proposals were submitted for this call and 2 have been taken forward to the grant agreement stage.
- 2010 Africa Call: 188 proposals were received for the Health topics in this call and 13 have been taken forward to the grant agreement stage.
- 2010 Alternatives Call: 31 proposals were received and seven have been taken forward to the grant agreement stage.
- 2010 ERANET Call: 4 proposals were submitted to this call and two have been taken forward to the grant agreement stage.
